Can vancomycin and nitrofurantoin exacerbate Clostridioides difficile (C. difficile) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Vancomycin and C. difficile Infection

  • The use of vancomycin as a treatment for Clostridioides difficile (C. difficile) infection has been studied extensively 1, 2, 3, 4, 5.
  • Vancomycin has been shown to be effective in preventing recurrent C. difficile infection in patients who have been previously diagnosed with the infection and are re-exposed to antibiotics 1, 5.
  • However, the evidence does not suggest that vancomycin exacerbates C. difficile infection 1, 2, 3, 4, 5.

Nitrofurantoin and C. difficile Infection

  • There is no direct evidence in the provided studies to suggest that nitrofurantoin exacerbates C. difficile infection.
  • The studies primarily focus on the use of vancomycin and metronidazole in the treatment and prevention of C. difficile infection 1, 2, 3, 4, 5.

Comparison of Antibiotics

  • A meta-analysis comparing vancomycin and metronidazole for the treatment of C. difficile infection found no significant difference in therapeutic effects for non-severe cases, but vancomycin was more effective in severe cases 4.
  • The use of oral vancomycin as secondary prophylaxis has been shown to decrease the risk of further recurrence in patients with a history of recurrent C. difficile infection who are re-exposed to antibiotics 1.

References

Research

Use of Oral Vancomycin for Clostridioides difficile Infection and the Risk of Vancomycin-Resistant Enterococci.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020

Research

Oral vancomycin versus metronidazole for the treatment of Clostridioides difficile infection: Meta-analysis of randomized controlled trials.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018

Research

Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic Antimicrobial Agents.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.